Mehregan Fatemeh Fereshteh, Ziaee Vahid, Ahmadinejad Zahra, Tahghighi Fatemeh, Sabouni Farah, Moradinejad Mohamad-Hassan
Children's Medical Center, Pediatrics Center of Excellence ; Shahid Beheshti University of Medical Sciences.
Pediatric Rheumatology Research Group, Rheumatology Research Center ; Department of Pediatrics.
Iran J Pediatr. 2014 Oct;24(5):598-602. Epub 2014 Oct 24.
The periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome is a nonhereditary idiopathic febrile syndrome belonging to the group of autoinflammatory diseases. No longtime sequel was reported in this disease. Early diagnosis can lead physicians to treatment of this disorder with a short course steroid application and provide satisfaction of the patient's family.
This study is a prospective review of patients diagnosed with PFAPA syndrome who were registered in Iranian Periodic Fever and Autoinflammatory Registry (IPFAIR) through periodic fever clinic in the Children's Medical Center, Pediatric Center of Excellence in Tehran, Iran from January 2013 to March 2014.
One hundred thirty patients were registered in our databases. Twenty-one (16.1%) patients including 15 males and 6 females had PFAPA. Normal growth was seen in all patients. The median age at onset was 18 months. The mean duration of fever was 4 days and the mean duration of intervals between fever episodes 21 days. Along with fever, all patients had characteristic symptoms. All patients were asymptomatic between fever episodes. Steroid was used in all patients and causing immediate reduction by 84.61%. Two patients received both steroid and colchicine because of their clinical feature and positive laboratory tests for PFAPA and familial Mediterranean fever. No patient received biological therapy or a tonsillectomy.
The long diagnostic delay of PFAPA gives cause to concern indicating a need for greater awareness of the disease so that the diagnosis may be made timely.
周期性发热、口疮性口炎、咽炎和颈淋巴结炎(PFAPA)综合征是一种属于自身炎症性疾病的非遗传性特发性发热综合征。该疾病尚无长期后遗症的报道。早期诊断可使医生采用短期类固醇应用来治疗这种疾病,并让患者家属满意。
本研究是一项对诊断为PFAPA综合征患者的前瞻性回顾,这些患者于2013年1月至2014年3月期间在伊朗德黑兰儿童医学中心卓越儿科中心的周期性发热诊所登记入伊朗周期性发热和自身炎症性疾病登记处(IPFAIR)。
130名患者被登记在我们的数据库中。21名(16.1%)患者患有PFAPA,其中包括15名男性和6名女性。所有患者生长发育正常。发病的中位年龄为18个月。发热的平均持续时间为4天,发热发作间期的平均持续时间为21天。除发热外,所有患者均有特征性症状。发热发作间期所有患者均无症状。所有患者均使用了类固醇,发热立即减退率为84.61%。两名患者因临床特征以及PFAPA和家族性地中海热的实验室检查阳性,同时接受了类固醇和秋水仙碱治疗。没有患者接受生物治疗或扁桃体切除术。
PFAPA的长期诊断延迟令人担忧,这表明需要提高对该疾病的认识,以便能够及时做出诊断。